Analyst Ratings for Mednax (MD) [Buys]

MD Rating Summary

MD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $29.75 (+3.4%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 23%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/3/2018 Credit Suisse
» Updated 2/19/2021
A.J. Rice Upgrade Outperform
(Neutral)
25.00
(26.00)
42.89
(28.77)
-32.92% Details
12/13/2017 Piper Sandler
» Updated 2/9/2018
N/A New Coverage Overweight
(N/A)
61.00
(58.00)
51.43
(28.77)
-44.06% Details
Like MD Ratings? Also take a look at GEO, RCM, MTG, WPG

MD Ratings News